Cargando…

The multitude of molecular analyses in cancer: the opening of Pandora’s box

The availability of large amounts of molecular data of unprecedented depth and width has instigated new paths of interdisciplinary activity in cancer research. Translation of such information to allow its optimal use in cancer therapy will require molecular biologists to embrace statistical and comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Russnes, Hege G, Lønning, Per E, Børresen-Dale, Anne-Lise, Lingjærde, Ole C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709983/
https://www.ncbi.nlm.nih.gov/pubmed/25316146
http://dx.doi.org/10.1186/s13059-014-0447-6
_version_ 1782409753787367424
author Russnes, Hege G
Lønning, Per E
Børresen-Dale, Anne-Lise
Lingjærde, Ole C
author_facet Russnes, Hege G
Lønning, Per E
Børresen-Dale, Anne-Lise
Lingjærde, Ole C
author_sort Russnes, Hege G
collection PubMed
description The availability of large amounts of molecular data of unprecedented depth and width has instigated new paths of interdisciplinary activity in cancer research. Translation of such information to allow its optimal use in cancer therapy will require molecular biologists to embrace statistical and computational concepts and models. Progress in science has been and should be driven by our innate curiosity. This is the human quality that led Pandora to open the forbidden box, and like her, we do not know the nature or consequences of the output resulting from our actions. Throughout history, ground-breaking scientific achievements have been closely linked to advances in technology. The microscope and the telescope are examples of inventions that profoundly increased the amount of observable features that further led to paradigmatic shifts in our understanding of life and the Universe. In cell biology, the microscope revealed details of different types of tissue and their cellular composition; it revealed cells, their structures and their ability to divide, develop and die. Further, the molecular compositions of individual cell types were revealed gradually by generations of scientists. For each level of insight gained, new mathematical and statistical descriptive and analytical tools were needed (Figure 1a). The integration of knowledge of ever-increasing depth and width in order to develop useful therapies that can prevent and cure diseases such as cancer will continue to require the joint effort of scientists in biology, medicine, statistics, mathematics and computation. Here, we discuss some major challenges that lie ahead of us and why we believe that a deeper integration of biology and medicine with mathematics and statistics is required to gain the most from the diverse and extensive body of data now being generated. We also argue that to take full advantage of current technological opportunities, we must explore biomarkers using clinical studies that are optimally designed for this purpose. The need for a tight interdisciplinary collaboration has never been stronger.
format Online
Article
Text
id pubmed-4709983
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47099832016-01-13 The multitude of molecular analyses in cancer: the opening of Pandora’s box Russnes, Hege G Lønning, Per E Børresen-Dale, Anne-Lise Lingjærde, Ole C Genome Biol Opinion The availability of large amounts of molecular data of unprecedented depth and width has instigated new paths of interdisciplinary activity in cancer research. Translation of such information to allow its optimal use in cancer therapy will require molecular biologists to embrace statistical and computational concepts and models. Progress in science has been and should be driven by our innate curiosity. This is the human quality that led Pandora to open the forbidden box, and like her, we do not know the nature or consequences of the output resulting from our actions. Throughout history, ground-breaking scientific achievements have been closely linked to advances in technology. The microscope and the telescope are examples of inventions that profoundly increased the amount of observable features that further led to paradigmatic shifts in our understanding of life and the Universe. In cell biology, the microscope revealed details of different types of tissue and their cellular composition; it revealed cells, their structures and their ability to divide, develop and die. Further, the molecular compositions of individual cell types were revealed gradually by generations of scientists. For each level of insight gained, new mathematical and statistical descriptive and analytical tools were needed (Figure 1a). The integration of knowledge of ever-increasing depth and width in order to develop useful therapies that can prevent and cure diseases such as cancer will continue to require the joint effort of scientists in biology, medicine, statistics, mathematics and computation. Here, we discuss some major challenges that lie ahead of us and why we believe that a deeper integration of biology and medicine with mathematics and statistics is required to gain the most from the diverse and extensive body of data now being generated. We also argue that to take full advantage of current technological opportunities, we must explore biomarkers using clinical studies that are optimally designed for this purpose. The need for a tight interdisciplinary collaboration has never been stronger. BioMed Central 2014-09-03 2014 /pmc/articles/PMC4709983/ /pubmed/25316146 http://dx.doi.org/10.1186/s13059-014-0447-6 Text en © Russnes et al.; licensee BioMed Central Ltd. 2014 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Russnes, Hege G
Lønning, Per E
Børresen-Dale, Anne-Lise
Lingjærde, Ole C
The multitude of molecular analyses in cancer: the opening of Pandora’s box
title The multitude of molecular analyses in cancer: the opening of Pandora’s box
title_full The multitude of molecular analyses in cancer: the opening of Pandora’s box
title_fullStr The multitude of molecular analyses in cancer: the opening of Pandora’s box
title_full_unstemmed The multitude of molecular analyses in cancer: the opening of Pandora’s box
title_short The multitude of molecular analyses in cancer: the opening of Pandora’s box
title_sort multitude of molecular analyses in cancer: the opening of pandora’s box
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709983/
https://www.ncbi.nlm.nih.gov/pubmed/25316146
http://dx.doi.org/10.1186/s13059-014-0447-6
work_keys_str_mv AT russneshegeg themultitudeofmolecularanalysesincancertheopeningofpandorasbox
AT lønningpere themultitudeofmolecularanalysesincancertheopeningofpandorasbox
AT børresendaleannelise themultitudeofmolecularanalysesincancertheopeningofpandorasbox
AT lingjærdeolec themultitudeofmolecularanalysesincancertheopeningofpandorasbox
AT russneshegeg multitudeofmolecularanalysesincancertheopeningofpandorasbox
AT lønningpere multitudeofmolecularanalysesincancertheopeningofpandorasbox
AT børresendaleannelise multitudeofmolecularanalysesincancertheopeningofpandorasbox
AT lingjærdeolec multitudeofmolecularanalysesincancertheopeningofpandorasbox